Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)
Pfizer
Pfizer
Tomsk National Research Medical Center of the Russian Academy of Sciences
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
University of California, Davis
Replimune Inc.
Dana-Farber Cancer Institute
Carevive Systems, Inc.
University of Pennsylvania
Duke University
AstraZeneca
Poseida Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
AstraZeneca
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
University Health Network, Toronto
Eli Lilly and Company
Brigham and Women's Hospital
Dokuz Eylul University
Varian, a Siemens Healthineers Company
Complement Theory Inc.
Kaiser Permanente
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
AstraZeneca
Memorial Sloan Kettering Cancer Center
SystImmune Inc.
Astellas Pharma Inc
Eli Lilly and Company
M.D. Anderson Cancer Center
Pfizer
Vanderbilt-Ingram Cancer Center
Dana-Farber Cancer Institute
Jonsson Comprehensive Cancer Center
Milton S. Hershey Medical Center
Wake Forest University Health Sciences
Eli Lilly and Company
University of Alabama at Birmingham
University College, London
Memorial Sloan Kettering Cancer Center
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
Memorial Sloan Kettering Cancer Center
University of Leeds